ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Immunosuppressive Therapy and Acute Rejection in Combined Heart and Kidney Transplantation.

M. Gallo, J. Trivedi, D. Abramov, R. Vijayakrishnan, M. Slaughter.

University of Louisville, Louisville

Meeting: 2017 American Transplant Congress

Abstract number: C103

Keywords: Heart, Immunosuppression, Kidney, Rejection

Session Information

Date: Monday, May 1, 2017

Session Name: Poster Session C: Hearts and VADS: All Topics

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Related Abstracts
  • Incidence of Acute Rejection and Donor Specific Antibodies in Low-Immunological Risk Patients Treated by Tacrolimus and Mycophenolic Acid with or without Induction Therapy.
  • Conversion from Tacrolimus-Based to Everolimus-Based Immunosuppressive Therapy 3 Months After Living-Donor Kidney Transplantation: A Randomized-Controlled Clinical Trial.

Background. This study evaluated the management of immunosuppressive therapy and the incidence of acute heart rejection within 1 year from concomitant heart-kidney transplantation (cHTKx) compared to isolated heart transplant (HTx).

Methods.The United Network for Organ Sharing database was queried for cHKTx and HTx from January 2004 to June 2015. Immunosuppressive therapy data at time of surgery was compared between cHKTx and HTx. Recipients were compared for tacrolimus-based vs. cyclosporine-based immunosuppressive therapies. Incidence of acute heart rejection within 1 year requiring treatment was evaluated between cHKTx and HTx and stratified by different maintenance therapies.

Results. A total of 631 patients received cHKTx (female 20%) and 24099 received HTx (female 28%). In cHKTx group induction therapy with anti-lymphocyte drugs was used in 66% vs. 50% in HTx group (p<0.001). Tacrolimus-based maintenance therapy was used in 93% of cHKTx patiens vs. 78% of HTx patients (p<0.001). Other respective maintenance therapies in cHKTX and HTx groups were steroids (93% vs 87%, p=0.002) and mycophenolate mofetil (76% vs 76%, p=0.8). Incidence of patients treated for heart rejection during 1st year was significantly lower in cHKTX recipients 8.6% (9% female) compared to 22% in HTx (26% female) recipients. Rejection stratified by gender showed no differences in cHKTx group (9% vs 8%, p=0.8) whereas females had higher rejection in HTx group compared to males (27% vs 20%, p<0.001) within 1st year. Tacrolimus-based maintenance therapy (8.4%) reduced heart rejection during 1st year when compared to cyclosporine (12%, p<0.001) in cHKTx.

Conclusions. For combined heart and kidney transplants steroids, mycophenolate and tacrolimus are most commonly used for maintenance. Combined heart and kidney transplants have significantly lower heart rejection during 1st year of transplant compare to isolated heart transplant.

CITATION INFORMATION: Gallo M, Trivedi J, Abramov D, Vijayakrishnan R, Slaughter M. Immunosuppressive Therapy and Acute Rejection in Combined Heart and Kidney Transplantation. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Gallo M, Trivedi J, Abramov D, Vijayakrishnan R, Slaughter M. Immunosuppressive Therapy and Acute Rejection in Combined Heart and Kidney Transplantation. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/immunosuppressive-therapy-and-acute-rejection-in-combined-heart-and-kidney-transplantation/. Accessed March 8, 2021.

« Back to 2017 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.